APOE and atherosclerosis: In atherosclerosis, MitoTEMPOL improves the vulnerability characteristics of atherosclerotic plaques in ApoE-/-/SOD2+/- mice by reducing the expression of calpain-2, caspase-3 and matrix metalloproteinase-2, smooth muscle cell apoptosis and matrix degradation [224].